SyVento BioTech is thrilled to announce our participation in the prestigious TIDES USA conference, taking place in Boston, MA, from May 14th to 17th, 2024, at the Hynes Convention Center. Our Chief Technology Officer, Dominik Lipka, will be actively engaged in this leading event, fostering connections and gathering knowledge at the forefront of oligonucleotide and peptide therapeutics.
Why TIDES USA is Critical for SyVento:
TIDES USA serves as a premier platform for exploring the entire spectrum of advancements in mRNA therapeutics and genome editing products. From the earliest stages of discovery to late-stage development and commercialization, the conference delves into groundbreaking research and practical applications.
Key Areas of Focus for SyVento at TIDES USA:
We’ll gain valuable insights into targeted delivery approaches, mRNA therapeutic optimization, translation efficiency through Cap modifications, in vivo delivery methods, discovering new Cap analogs, AI-optimized mRNA design for improved stability, and novel ionizable lipids in the acceleration of RNA based therapeutics. This knowledge will be instrumental in refining our LNP platform for mRNA therapeutics.
